Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Current Assets (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Current Assets for 13 consecutive years, with $616.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets fell 18.05% year-over-year to $616.9 million, compared with a TTM value of $616.9 million through Sep 2025, down 18.05%, and an annual FY2024 reading of $724.5 million, down 3.14% over the prior year.
  • Current Assets was $616.9 million for Q3 2025 at Tandem Diabetes Care, roughly flat from $614.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $850.0 million in Q4 2022 and bottomed at $614.8 million in Q2 2025.
  • Average Current Assets over 5 years is $743.9 million, with a median of $752.8 million recorded in 2024.
  • The sharpest move saw Current Assets soared 135.59% in 2021, then dropped 18.05% in 2025.
  • Year by year, Current Assets stood at $811.5 million in 2021, then grew by 4.74% to $850.0 million in 2022, then dropped by 12.0% to $748.0 million in 2023, then fell by 3.14% to $724.5 million in 2024, then fell by 14.84% to $616.9 million in 2025.
  • Business Quant data shows Current Assets for TNDM at $616.9 million in Q3 2025, $614.8 million in Q2 2025, and $663.4 million in Q1 2025.